(Total Views: 500)
Posted On: 06/22/2022 1:43:20 PM
Post# of 153832
Agreed - NASH and BLA are the keys to the castle right now. I've been saying a new CEO, but maybe that's just not in the cards right now.
Frankly, the WSJ article talked about how many biotechs find partners when they are between CEOs, so that could be the case.
But i agree - I think a thorough explanation of NASH is key here. Some on the board have done a great job of laying out the results, but it's time for the company to opine on them directly to shareholders.
I'm cautiously optimistic for this call. Of course, i've also been cautiously optimistic for every call they've had over the past 6+ years that i've been invested....
Frankly, the WSJ article talked about how many biotechs find partners when they are between CEOs, so that could be the case.
But i agree - I think a thorough explanation of NASH is key here. Some on the board have done a great job of laying out the results, but it's time for the company to opine on them directly to shareholders.
I'm cautiously optimistic for this call. Of course, i've also been cautiously optimistic for every call they've had over the past 6+ years that i've been invested....
(3)
(0)
